|
|
Volumn 7, Issue 6, 2000, Pages 669-685
|
|
Cellular and molecular biology of cardiac transplant rejection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOANTIGEN;
AZATHIOPRINE;
CD8 ANTIGEN;
CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C5;
CYCLOSPORIN;
FINGOLIMOD;
GLUCOCORTICOID;
HISTOCOMPATIBILITY ANTIGEN;
HLA A ANTIGEN;
HLA ANTIBODY;
HLA B ANTIGEN;
HLA C ANTIGEN;
HLA DQ ANTIGEN;
HLA DR ANTIGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LEFLUNOMIDE;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
T LYMPHOCYTE RECEPTOR;
TACROLIMUS;
ALLOTRANSPLANTATION;
ANTIGEN PRESENTATION;
ANTIGEN PRESENTING CELL;
ARTICLE;
B LYMPHOCYTE;
CELLULAR IMMUNITY;
COMPLEMENT SYSTEM;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DISEASE CLASSIFICATION;
DRUG MECHANISM;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HELPER CELL;
HLA SYSTEM;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTE FUNCTION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE ACTIVATION;
|
|
EID: 0034526195
PISSN: 10713581
EISSN: None
Source Type: Journal
DOI: 10.1067/mnc.2000.111128 Document Type: Article |
|
Times cited : (13)
|
|
References (9)
|
